Clinical Trials Directory

Trials / Completed

CompletedNCT03811119

Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial

MANTA™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
151 (actual)
Sponsor
Erasmus Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To investigate whether the collagen-based MANTA vascular closure device (VCD) is superior to suture-based VCDs in preventing vascular access site complications in patients undergoing transfemoral transcatheter aortic valve replacement.

Detailed description

see summary

Conditions

Interventions

TypeNameDescription
DEVICEMANTA vascular closure deviceCollagen based vascular closure device
DEVICESuture based vascular closure deviceSuture based vascular closure device (ProGlide)

Timeline

Start date
2018-10-30
Primary completion
2020-02-01
Completion
2020-04-30
First posted
2019-01-22
Last updated
2021-03-29

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03811119. Inclusion in this directory is not an endorsement.